BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22001826)

  • 1. Prescribing proton pump inhibitor and clopidogrel together: current state of recommendations.
    Abraham NS
    Curr Opin Gastroenterol; 2011 Oct; 27(6):558-64. PubMed ID: 22001826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton pump inhibitor and clopidogrel interaction: fact or fiction?
    Laine L; Hennekens C
    Am J Gastroenterol; 2010 Jan; 105(1):34-41. PubMed ID: 19904241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitors and clopidogrel: is it a significant drug interaction?
    Oyetayo OO; Talbert RL
    Expert Opin Drug Saf; 2010 Jul; 9(4):593-602. PubMed ID: 20377472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitor and clopidogrel interaction: the case for watchful waiting.
    Tan VP; Yan BP; Hunt RH; Wong BC
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1342-7. PubMed ID: 20659222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPI use in patients commenced on clopidogrel: a retrospective cross-sectional evaluation.
    Luinstra M; Naunton M; Peterson GM; Bereznicki L
    J Clin Pharm Ther; 2010 Apr; 35(2):213-7. PubMed ID: 20456741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of individual proton pump inhibitors on cardiovascular events in patients treated with clopidogrel following coronary stenting: results from the Ibaraki Cardiac Assessment Study Registry.
    Aihara H; Sato A; Takeyasu N; Nishina H; Hoshi T; Akiyama D; Kakefuda Y; Watabe H; Aonuma K;
    Catheter Cardiovasc Interv; 2012 Oct; 80(4):556-63. PubMed ID: 22234956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current standings of the proton pump inhibitor and clopidogrel co-therapy: review on an evolving field with the eyes of the gastroenterologist.
    Juhász M; Herszényi L; Tulassay Z
    Digestion; 2010; 81(1):10-5. PubMed ID: 20029203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of co-administration of clopidogrel and proton pump inhibitors.
    Shrestha K; Hughes JD; Lee YP; Parsons R
    Qual Prim Care; 2011; 19(1):35-42. PubMed ID: 21703110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clopidogrel and proton pump inhibitors: influence of pharmacological interactions on clinical outcomes and mechanistic explanations.
    Tantry US; Kereiakes DJ; Gurbel PA
    JACC Cardiovasc Interv; 2011 Apr; 4(4):365-80. PubMed ID: 21511216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single antiplatelet therapy for patients with previous gastrointestinal bleeds.
    Gellatly RM; Ackman ML
    Ann Pharmacother; 2008 Jun; 42(6):836-40. PubMed ID: 18413689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug interaction between clopidogrel and proton pump inhibitors.
    Liu TJ; Jackevicius CA
    Pharmacotherapy; 2010 Mar; 30(3):275-89. PubMed ID: 20180611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversy of proton pump inhibitor and clopidogrel interaction: a review.
    Tan HJ
    J Dig Dis; 2010 Dec; 11(6):334-42. PubMed ID: 21091895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent safety concerns with proton pump inhibitors.
    Chen J; Yuan YC; Leontiadis GI; Howden CW
    J Clin Gastroenterol; 2012 Feb; 46(2):93-114. PubMed ID: 22227731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
    Hsu PI
    J Gastroenterol Hepatol; 2012 Apr; 27(4):654-61. PubMed ID: 22283743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clopidogrel and PPI interaction: clinically relevant or not?
    Harrison RW; Mahaffey KW
    Curr Cardiol Rep; 2012 Feb; 14(1):49-58. PubMed ID: 22090195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year clinical outcome in patients with acute coronary syndrome treated with concomitant use of clopidogrel and proton pump inhibitors: results from a regional cohort study.
    Ortolani P; Marino M; Marzocchi A; De Palma R; Branzi A
    J Cardiovasc Med (Hagerstown); 2012 Dec; 13(12):783-9. PubMed ID: 21252697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-prescription of gastro-protectants in hospitalized patients: an analysis of what we do and what we think we do.
    Doherty GA; Cannon MD; Lynch KM; Ayoubi KZ; Harewood GC; Patchett SE; Murray FE
    J Clin Gastroenterol; 2010 Mar; 44(3):e51-6. PubMed ID: 19609216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Proton-Pump Inhibitors in High-Risk Cardiovascular Subsets of the COGENT Trial.
    Vaduganathan M; Cannon CP; Cryer BL; Liu Y; Hsieh WH; Doros G; Cohen M; Lanas A; Schnitzer TJ; Shook TL; Lapuerta P; Goldsmith MA; Laine L; Bhatt DL;
    Am J Med; 2016 Sep; 129(9):1002-5. PubMed ID: 27143321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of patients with high gastrointestinal risk on antiplatelet therapy.
    Cryer B
    Gastroenterol Clin North Am; 2009 Jun; 38(2):289-303. PubMed ID: 19446259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.